StockData
Myomo, Inc. logo

Myomo, Inc. (MYO) stock

MYONYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3033% below fair value
$0.88−0.04 (-4.23%)

Close on Nov 18, 2026Market cap $34.85MP/E –Yield –

Myomo operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Myomo's operating cash flow for the twelve months ending Jun 30, 2026 was -$7.11M. For fiscal 2025 it was -$14.51M. The highest annual figure on record is -$3.20M in fiscal 2016.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$14.51M–
FY2024Dec 31, 2024-$3.29M–
FY2023Dec 31, 2023-$6.17M–
FY2022Dec 31, 2022-$10.23M–
FY2021Dec 31, 2021-$9.55M–
FY2020Dec 31, 2020-$9.03M–
FY2019Dec 31, 2019-$10.34M–
FY2018Dec 31, 2018-$9.61M–
FY2017Dec 31, 2017-$6.15M–
FY2016Dec 31, 2016-$3.20M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.94M–
Q1 FY2026Mar 31, 2026-$2.20M–
Q4 FY2025Dec 31, 2025-$1.14M-133.9%
Q3 FY2025Sep 30, 2025-$1.83M–
Q2 FY2025Jun 30, 2025-$8.87M–
Q1 FY2025Mar 31, 2025-$2.68M–
Q4 FY2024Dec 31, 2024$3.37M–
Q3 FY2024Sep 30, 2024-$1.49M–
Q2 FY2024Jun 30, 2024-$1.92M–
Q1 FY2024Mar 31, 2024-$3.25M–
Q4 FY2023Dec 31, 2023-$2.36M–
Q3 FY2023Sep 30, 2023-$1.71M–
Q2 FY2023Jun 30, 2023-$285.52K–
Q1 FY2023Mar 31, 2023-$1.82M–
Q4 FY2022Dec 31, 2022-$2.46M–
Q3 FY2022Sep 30, 2022-$2.80M–
Q2 FY2022Jun 30, 2022-$2.65M–
Q1 FY2022Mar 31, 2022-$2.32M–
Q4 FY2021Dec 31, 2021-$1.83M–
Q3 FY2021Sep 30, 2021-$2.21M–
Q2 FY2021Jun 30, 2021-$3.40M–
Q1 FY2021Mar 31, 2021-$2.11M–
Q4 FY2020Dec 31, 2020-$1.15M–
Q3 FY2020Sep 30, 2020-$1.77M–
Q2 FY2020Jun 30, 2020-$3.67M–
Q1 FY2020Mar 31, 2020-$2.45M–
Q4 FY2019Dec 31, 2019-$2.64M–
Q3 FY2019Sep 30, 2019-$2.29M–
Q2 FY2019Jun 30, 2019-$2.29M–
Q1 FY2019Mar 31, 2019-$3.12M–
Q4 FY2018Dec 31, 2018-$2.51M–
Q3 FY2018Sep 30, 2018-$2.48M–
Q2 FY2018Jun 30, 2018-$2.34M–
Q1 FY2018Mar 31, 2018-$2.27M–
Q4 FY2017Dec 31, 2017-$1.54M–
Q3 FY2017Sep 30, 2017-$1.86M–
Q2 FY2017Jun 30, 2017-$1.59M–
Q1 FY2017Mar 31, 2017-$1.16M–
Q4 FY2016Dec 31, 2016-$903.86K–
Q3 FY2016Sep 30, 2016-$1.31M–

More Myomo figures

See a number that looks wrong?